Pulmonary alveolar proteinosis

Respiratory Care

Volumn 56, Issue 7, 2011, Pages 1016-1028

  Khan, Ajmal ^a   Agarwal, Ritesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alveoli; Autoimmune disease; Pulmonary alveolar proteinosis; Surfactant

Indexed keywords

AMBROXOL; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHYMOTRYPSIN; CYTOKERATIN 9; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; LACTATE DEHYDROGENASE; LUNG SURFACTANT; PROTEIN KL 6; RITUXIMAB; SQUAMOUS CELL CARCINOMA ANTIGEN; SURFACTANT PROTEIN A; TRYPSIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ABNORMAL RESPIRATORY SOUND; ACQUIRED LUNG ALVEOLUS PROTEINOSIS; AEROSOL; AGE DISTRIBUTION; ANTIBODY TITER; CLINICAL FEATURE; CONGENITAL LUNG ALVEOLUS PROTEINOSIS; COR PULMONALE; COUGHING; CYANOSIS; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG TOLERABILITY; DYSPNEA; ELECTRON MICROSCOPY; ENZYMATIC DEBRIDEMENT; FEVER; FLUSHING; GAS EXCHANGE; HEART TRANSPLANTATION; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOTENSION; IMMUNOPATHOGENESIS; INFECTION; INVOLUNTARY LEG SPASM; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG LAVAGE; LUNG TRANSPLANTATION; MICROSCOPY; MUSCLE SPASM; MUSCULOSKELETAL PAIN; NAUSEA AND VOMITING; NONHUMAN; OXYGENATION; PLASMAPHERESIS; PNEUMOTHORAX; PREVALENCE; RESPIRATORY FAILURE; REVIEW; RIGOR; SEX RATIO; SIDE EFFECT; SPUTUM; SYNCOPE; SYSTEMATIC REVIEW; TACHYCARDIA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ALGORITHMS; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; BRONCHOALVEOLAR LAVAGE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LUNG; PLASMAPHERESIS; PULMONARY ALVEOLAR PROTEINOSIS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960712114     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01125     Document Type: Review

References (203)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958;258(23):1123-1142.
2. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349(26):2527-2539.
3. Burgess AW, Camakaris J, Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 1977;252(6):1998-2003.
4. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264(5159): 713-716.
5. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91(12):5592-5596.
6. Sakagami T, Uchida K, Suzuki T, Carey BC, Wood RE, Wert SE, et al. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 2009;361(27):2679-2681.
7. Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, et al. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 2010;182(1):49-61.
8. Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190(6):875-880.
9. Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008;177(7):752-762.
10. Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996;335(25):1924-1925.
11. Ben-Dov I, Kishinevski Y, Roznman J, Soliman A, Bishara H, Zelligson E, et al. Pulmonary alveolar proteinosis in Israel: ethnic clustering. Isr Med Assoc J 1999;1(2):75-78.
12. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166(2):215-235.
13. Xu Z, Jing J, Wang H, Xu F, Wang J. Pulmonary alveolar proteinosis in China: a systematic review of 241 cases. Respirology 2009;14(5):761-766.
14. Byun MK, Kim DS, Kim YW, Chung MP, Shim JJ, Cha SI, et al. Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population. J Korean Med Sci 2010;25(3): 393-398.
15. Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775-802.
16. Gearing DP, King JA, Gough NM, Nicola NA. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 1989;8(12):3667-3676.
17. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GMCSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990;87(24):9655-9659.
18. Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MS, et al. PU. 1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. AmJ Physiol Lung Cell Mol Physiol 2003;285(5):L1132-1136.
19. Akagawa KS, Kamoshita K, Tokunaga T. Effects of granulocytemacrophage colony-stimulating factor and colony-stimulating factor- 1 on the proliferation and differentiation of murine alveolar macrophages. J Immunol 1988;141(10):3383-3390.
20. Chen BD, Mueller M, Chou TH. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation. J Immunol 1988;141(1): 139-144.
21. Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004;103(3):1089-1098.
22. Golde DW, Territo M, Finley TN, Cline MJ. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976; 85(3):304-309.
23. Harris JO. Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest 1979;76(2):156-159.
24. Gonzalez-Rothi RJ, Harris JO. Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages. Chest 1986; 90(5):656-661.
25. Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975;30(2):121-132.
26. Singh G, Katyal SL, Bedrossian CW, Rogers RM. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983;83(1):82-86.
27. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993;103(2):496-499.
28. Ramirez J, Harlan WR Jr. Pulmonary alveolar proteinosis: nature and origin of alveolar lipid. Am J Med 1968;45(4):502-512.
29. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999;276(4 Pt 1):L556-563.
30. Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol 2000;95(2):85-92.
31. Carraway MS, Ghio AJ, Carter JD, Piantadosi CA. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 161(4 Pt 1):1294-1299.
32. Costabel U, Nakata K. Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune? Am J Respir Crit Care Med 2010;181(5):427-428.
33. Gilmore LB, Talley FA, Hook GE. Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis. Am J Pathol 1988;133(2):252-264.
34. Verbeken EK, Demedts M, Vanwing J, Deneffe G, Lauweryns JM. Pulmonary phospholipid accumulation distal to an obstructed bronchus: a morphologic study. Arch Pathol Lab Med 1989;113(8):886- 890.
35. Tran Van Nhieu J, Vojtek AM, Bernaudin JF, Escudier E, Fleury- Feith J. Pulmonary alveolar proteinosis associated with Pneumocystis carinii: ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients. Chest 1990;98(4):801-805.
36. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328(6):406-410.
37. Dirksen U, Hattenhorst U, Schneider P, Schroten H, Gobel U, Bocking A, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 1998;92(4):1097-1103.
38. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350(13):1296-1303.
39. Teja K, Cooper PH, Squires JE, Schnatterly PT. Pulmonary alveolar proteinosis in four siblings. N Engl J Med 1981;305(23):1390-1392.
40. Eldar M, Shoenfeld Y, Zaizov R, Fogel R, Asherov J, Liban E, et al. Pulmonary alveolar proteinosis associated with fanconi's anemia. Respiration 1979;38(3):177-179.
41. Dirksen U, Moritz T, Burdach S, Flasshove M, Hanenberg H. Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches. Klin Padiatr 1999;211(4):329-335.
42. Ohnishi T, Yamada G, Shijubo N, Takagi-Takahashi Y, Itoh T, Takahashi H, et al. Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome. Intern Med 2003;42(2): 187-190.
43. Kajiume T, Yoshimi S, Nagita A, Kobayashi K, Kataoka N, Nakajima M, et al. A case of myelodysplastic syndrome complicated by pulmonary alveolar proteinosis with a high serum KL-6 level. Pediatr Hematol Oncol 1999;16(4):367-371.
44. Birsak CA, van Rossem RN, Nijhuis-Heddes JM, Maartense E. Pulmonary alveolar proteinosis: a complication in patients with hematologic malignancy. Neth J Med 2000;56(5):193-197.
45. Du EZ, Yung GL, Le DT, Masliah E, Yi ES, Friedman PJ. Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient. J Thorac Imaging 2001;16(4): 307-309.
46. Breslow A, Snow P, Rosenberg MH. Pulmonary Alveolar Proteinosis and Chronic Lymphatic Leukemia Med Ann Dist Columbia 1965;34:209-212.
47. Aymard JP, Gyger M, Lavallee R, Legresley LP, Desy M. A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia: a peculiar pathologic aspect of busulfan lung? Cancer 1984;53(4):954-956.
48. Cheng SL, Kuo PH, Yang PC, Luh KT. Bilateral alveolar infiltrates in a 29-year-old man with chronic myelogenous leukemia. Chest 2002;122(6):2238-2241.
49. Ceruti M, Rodi G, Stella GM, Adami A, Bolongaro A, Baritussio A, et al. Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Orphanet J Rare Dis 2007;2:14.
50. Santamaria F, Brancaccio G, Parenti G, Francalanci P, Squitieri C, Sebastio G, et al. Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance. J Pediatr 2004;145(2):268-272.
51. Bjurulf B, Spetalen S, Erichsen A, Vanier MT, Strom EH, Stromme P. Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: morphological findings in lung and nervous tissue. Med Sci Monit 2008;14(8):CS71-CS75.
52. Griese M, Brasch F, Aldana VR, Cabrera MM, Goelnitz U, Ikonen E, et al. Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis. Clin Genet 2010;77(2):119-130.
53. Haworth JC, Hoogstraten J, Taylor H. Thymic alymphoplasia. Arch Dis Child 1967;42(221):40-54.
54. Webster JR, Jr., Battifora H, Furey C, Harrison RA, Shapiro B. Pulmonary alveolar proteinosis in two siblings with decreased immunoglobulin A. Am J Med 1980;69(5):786-789.
55. Vethanayagam D, Pugsley S, Dunn EJ, Russell D, Kay JM, Allen C. Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation. Can Respir J 2000;7(4):338-342.
56. Yousem SA. Alveolar lipoproteinosis in lung allograft recipients. Hum Pathol 1997;28(12):1383-1386.
57. Fisher M, Roggli V, Merten D, Mulvihill D, Spock A. Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation. Pediatr Pathol 1992;12(3): 365-383.
58. Steens RD, Summers QA, Tarala RA. Pulmonary alveolar proteinosis in association with Fanconi's anemia and psoriasis: a possible common pathogenetic mechanism. Chest 1992;102(2):637-638.
59. Merino-Angulo A, Perez-Marti M, Diaz de Otazu R. Pulmonary alveolar phospholipoproteinosis associated with amyloidosis. Chest 1990;98(4):1048.
60. Mork JN, Johnson JR, Zinneman HH, Bjorgen J. Pulmonary alveolar proteinosis associated with IgG monoclonal gammopathy. Arch Intern Med 1968;121(3):278-283.
61. Buechner HA, Ansari A. Acute silico-proteinosis: a new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969;55(4):274-278.
62. Xipell JM, Ham KN, Price CG, Thomas DP. Acute silicoproteinosis. Thorax 1977;32(1):104-111.
63. Thind GS. Acute pulmonary alveolar proteinosis due to exposure to cotton dust. Lung India 2009;26(4):152-154.
64. McCunney RJ, Godefroi R. Pulmonary alveolar proteinosis and cement dust: a case report. J Occup Med 1989;31(3):233-237.
65. Keller CA, Frost A, Cagle PT, Abraham JL. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest 1995;108(1):277-280.
66. Miller RR, Churg AM, Hutcheon M, Lom S. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984; 130(2):312-315.
67. Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 2010;181(5):458-464.
68. Xiao YL, Cai HR, Wang YH, Meng FQ, Zhang DP. Pulmonary alveolar proteinosis in an indium-processing worker. Chin Med J (Engl) 2010;123(10):1347-1350.
69. Ballantyne B. Pulmonary alveolar phospholipoproteinosis induced by Orasol Navy Blue dust. Hum Exp Toxicol 1994;13(10):694-699.
70. McDonald JW, Alvarez F, Keller CA. Pulmonary alveolar proteinosis in association with household exposure to fibrous insulation material. Chest 2000;117(6):1813-1817.
71. Dawkins SA, Gerhard H, Nevin M. Pulmonary alveolar proteinosis: a possible sequel of NO2 exposure. J Occup Med 1991;33(5):638-641.
72. Burbank B, Morrione TG, Cutler SS. Pulmonary alveolar proteinosis and nocardiosis. Am J Med 1960;28:1002-1007.
73. Martinez-Maldonado M, Ramirez de Arellano G. Pulmonary alveolar proteinosis, nocardiosis and chronic granulocytic leukemia. South Med J 1966;59(8):901-905.
74. Pascual J, Gomez Aguinaga MA, Vidal R, Maudes A, Sureda A, Gomez Mampaso E, et al. Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage. Postgrad Med J 1989; 65(767):674-677.
75. Ruben FL, Talamo TS. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med 1986;80(6):1187-1190.
76. Nachajon RV, Rutstein RM, Rudy BJ, Collins MH. Pulmonary alveolar proteinosis in an HIV-infected child. Pediatr Pulmonol 1997;24(4):292-295.
77. Ranchod M, Bissell M. Pulmonary alveolar proteinosis and cytomegalovirus infection. Arch Pathol Lab Med 1979;103(3):139-142.
78. Hartung M, Salfelder K. Pulmonary alveolar proteinosis and histoplasmosis: report of three cases. Virchows Arch A Pathol Anat Histol 1975;368(4):281-287.
79. Sunderland WA, Campbell RA, Edwards MJ. Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy. J Pediatr 1972;80(3):450-456.
80. Bergman F, Linell F. Cryptococcosis as a cause of pulmonary alveolar proteinosis. Acta Pathol Microbiol Scand 1961;53:217-224.
81. Lathan SR Jr, Williams JD Jr, McLean RL, Ramirez J. Pulmonary alveolar proteinosis: treatment of a case complicated by tuberculosis. Chest 1971;59(4):452-454.
82. Pereira-Silva JL, Marinho MM, Veloso TV, Coelho JJ. Pulmonary alveolar proteinosis and tuberculosis in a diabetic patient: a rare or a seldom-diagnosed association? Braz J Infect Dis 2002;6(4):188-195.
83. Steer A. Focal pulmonary alveolar proteinosis in pulmonary tuberculosis. Arch Pathol 1969;87(3):347-352.
84. Reyes JM, Putong PB. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 1980;74(4): 478-485.
85. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore) 1994;73(2):103-109.
86. Bakhos R, Gattuso P, Arcot C, Reddy VB. Pulmonary alveolar proteinosis: an unusual association with Mycobacterium avium-intracellulare infection and lymphocytic interstitial pneumonia. South Med J 1996;89(8):801-802.
87. Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest 1998;114(5):1357-1362.
88. Rubinstein I, Mullen JB, Hoffstein V. Morphologic diagnosis of idiopathic pulmonary alveolar lipoproteinosis-revisited. Arch Intern Med 1988;148(4):813-816.
89. Mazzone P, Thomassen MJ, Kavuru M. Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Cleve Clin J Med 2001;68(12):977-978.
90. Asamoto H, Kitaichi M, Nishimura K, Itoh H, Izumi T. [Primary pulmonary alveolar proteinosis: clinical observation of 68 patients in Japan]. Jpn J Thorac Dis 1995;33(8):835-845.Article in Japanese.
91. Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149(3 Pt 1):788-794.
92. Dahmash NS, Al-Majed S, Sassi M. Fulminant respiratory failure secondary to alveolar proteinosis. Ann Saudi Med 1993;13(4):375-377.
93. Dexter ME, Cosgrove GP, Douglas IS. Managing a rare condition presenting with intractable hypoxemic respiratory failure. Chest 2007;131(1):320-327.
94. Gacouin A, Le Tulzo Y, Suprin E, Briens E, Bernard M, Camus C, et al. Acute respiratory failure caused by secondary alveolar proteinosis in a patient with acute myeloid leukemia: a case report. Intensive Care Med 1998;24(3):265-267.
95. Cohen ES, Elpern E, Silver MR. Pulmonary alveolar proteinosis causing severe hypoxemic respiratory failure treated with sequential whole-lung lavage utilizing venovenous extracorporeal membrane oxygenation: a case report and review. Chest 2001;120(3): 1024-1026.
96. Anton HC, Gray B. Pulmonary alveolar proteinosis presenting with pneumothorax. Clin Radiol 1967;18(4):428-431.
97. Oliva PB, Vogel JH. Reactive pulmonary hypertension in alveolar proteinosis. Chest 1970;58(2):167-168.
98. Selecky PA, Wasserman K, Benfield JR, Lippmann M. The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience. Ann Thorac Surg 1977; 24(5):451-461.
99. Rubin E, Weisbrod GL, Sanders DE. Pulmonary alveolar proteinosis: relationship to silicosis and pulmonary infection. Radiology 1980;135(1):35-41.
100. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 1987;62(6):499-518.
101. Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM. CT features of pulmonary alveolar proteinosis. AJR 2001;176(5):1287-1294.
102. Lee KN, Levin DL, Webb WR, Chen D, Storto ML, Golden JA. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations. Chest 1997;111(4):989-995.
103. Kang EY, Grenier P, Laurent F, Muller NL. Interlobular septal thickening: patterns at high-resolution computed tomography. J Thorac Imaging 1996;11(4):260-264.
104. Johkoh T, Itoh H, Muller NL, Ichikado K, Nakamura H, Ikezoe J, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology 1999;211(1):155-160.
105. Murayama S, Murakami J, Yabuuchi H, Soeda H, Masuda K. "Crazy paving appearance" on high resolutionCTin various diseases. JComput Assist Tomogr 1999;23(5):749-752.
106. Matsuno O, Hayama Y, Honda H, Yamane H, Yamamoto S, Ueno K, et al. Crazy-paving sign in high-resolution computed tomography in parainfluenza virus pneumonia. Radiography 2010;16:160-162.
107. Marchiori E, Gasparetto TD, Escuissato DL, Zanetti G. Leptospirosis of the lung presenting with crazy-paving pattern: correlation between the high-resolution CT and pathological findings. Rev Port Pneumol 2008;14(6):887-891.
108. Hisada T, Ishizuka T, Tomizawa Y, Iwasaki Y, Kawata T, Dobashi K, et al. "Crazy-paving" appearance in systemic lupus erythematosus. Intern Med 2006;45(1):29-30.
109. Coche E, Weynand B, Noirhomme P, Pieters T. Non-specific interstitial pneumonia showing a "crazy paving" pattern on high resolution CT. Br J Radiol 2001;74(878):189-191.
110. Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am J Roentgenol 1990;154(5):983-987.
111. Franquet T, Gimenez A, Bordes R, Rodriguez-Arias JM, Castella J. The crazy-paving pattern in exogenous lipoid pneumonia: CT-pathologic correlation. AJR Am J Roentgenol 1998;170(2):315-317.
112. Marchiori E, Zanetti G, Mano CM, Irion KL, Daltro PA, Hochhegger B. Lipoid pneumonia in 53 patients after aspiration of mineral oil: comparison of high-resolution computed tomography findings in adults and children. J Comput Assist Tomogr 2010;34(1):9-12.
113. Tan RT, Kuzo RS. High-resolution CT findings of mucinous bronchioloalveolar carcinoma: a case of pseudopulmonary alveolar proteinosis. AJR Am J Roentgenol 1997;168(1):99-100.
114. Kim KI, Lee KN, Tomiyama N, Johkoh T, Ichikado K, Kim CW, et al. Near drowning: thin-section CT findings in six patients. J Comput Assist Tomogr 2000;24(4):562-566.
115. Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, et al. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 2009;136(5):1348-1355.
116. Mikami T, Yamamoto Y, Yokoyama M, Okayasu I. Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid. J Clin Pathol 1997;50(12):981-984.
117. Burkhalter A, Silverman JF, Hopkins MB 3rd, Geisinger KR. Bronchoalveolar lavage cytology in pulmonary alveolar proteinosis.AmJ Clin Pathol 1996;106(4):504-510.
118. Martin RJ, Coalson JJ, Rogers RM, Horton FO, Manous LE. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980;121(5):819-825.
119. Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 1993; 142(1):241-248.
120. Honda Y, Kataoka K, Hayashi H, Takahashi H, Suzuki A, Akino T. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Clin Chim Acta 1989;181(1):11-18.
121. Maygarden SJ, Iacocca MV, Funkhouser WK, Novotny DB. Pulmonary alveolar proteinosis: a spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid. Diagn Cytopathol 2001;24(6):389-395.
122. Hook GE, Gilmore LB, Talley FA. Multilamelled structures from the lungs of patients with pulmonary alveolar proteinosis. Lab Invest 1984;50(6):711-725.
123. Chou CW, Lin FC, Tung SM, Liou RD, Chang SC. Diagnosis of pulmonary alveolar proteinosis: usefulness of papanicolaou-stained smears of bronchoalveolar lavage fluid. Arch Intern Med 2001; 161(4):562-566.
124. Hirakata Y, Kobayashi J, Sugama Y, Kitamura S. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis. Eur Respir J 1995;8(5):689-696.
125. Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis: a review and an update. Chest 1997; 111(2):460-466.
126. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000;55(1):67-77.
127. Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, et al. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 2009;113(11):2547-2556.
128. Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;162(2 Pt 1):658-662.
129. Kariman K, Kylstra JA, Spock A. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung 1984;162(4):223-231.
130. Rogers RM, Levin DC, Gray BA, Moseley LW Jr. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978;118(2):255-264.
131. Inoue Y, Nakata K, Arai T, Tazawa R, Hamano E, Nukiwa T, et al. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology 2006;11(Suppl):S55-S60.
132. Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 2002;105(3):342-350.
133. Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005;171(10):1142-1149.
134. Lin FC, Chang GD, Chern MS, Chen YC, Chang SC. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis. Thorax 2006;61(6):528-534.
135. Seymour JF, Doyle IR, Nakata K, Presneill JJ, Schoch OD, Hamano E, et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 2003;58(3):252-257.
136. Arai T, Hamano E, Inoue Y, Ryushi T, Nukiwa T, Sakatani M, et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir Med 2004;98(12):1227-1230.
137. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999;159(2):646-678.
138. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152(6 Pt 1):1860-1866.
139. Kuroki Y, Tsutahara S, Shijubo N, Takahashi H, Shiratori M, Hattori A, et al. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 1993;147(3):723-729.
140. Lin FC, Chen YC, Chang SC. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. Mayo Clin Proc 2008;83(12):1344-1349.
141. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998;158(4):1294-1298.
142. Tazawa R, Nakata K, Inoue Y, Nukiwa T. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Respirology 2006;11(Suppl):S61-S64.
143. Fujishima T, Honda Y, Shijubo N, Takahashi H, Abe S. Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Respiration 1995;62(6):317-321.
144. Minakata Y, Kida Y, Nakanishi H, Nishimoto T, Yukawa S. Change in cytokeratin 19 fragment level according to the severity of pulmonary alveolar proteinosis. Intern Med 2001;40(10):1024-1027.
145. deMello DE, Lin Z. Pulmonary alveolar proteinosis: a review. Pediatr Pathol Mol Med 2001;20(5):413-432.
146. McCook TA, Kirks DR, Merten DF, Osborne DR, Spock A, Pratt PC. Pulmonary alveolar proteinosis in children. AJR 1981;137(5): 1023-1027.
147. Hamvas A, Nogee LM, Mallory GB Jr, Spray TL, Huddleston CB, August A, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997;130(2):231-239.
148. Huddleston CB, Bloch JB, Sweet SC, de la Morena M, Patterson GA, Mendeloff EN. Lung transplantation in children. Ann Surg 2002;236(3):270-276.
149. Bellon G, Ninet J, Louis D, Jocteur-Monrozier D, Champsaur G. Heart-lung transplantation in a 16-month-old infant. Chest 1992; 102(1):299-300.
150. Numata A, Matsuishi E, Koyanagi K, Saito S, Miyamoto Y, Irie K, et al. Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Am J Hematol 2006;81(2):107-109.
151. Ramirez J, Campbell GD. Pulmonary alveolar proteinosis: endobronchial treatment. Ann Intern Med 1965;63:429-441.
152. Ramirez J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med 1963; 112:419-431.
153. Ramirez J, Kieffer RF Jr, Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med 1965;63(5):819-828.
154. Wasserman K, Blank N, Fletcher G. Lung lavage (alveolar washing) in alveolar proteinosis. Am J Med 1968;44(4):611-617.
155. Ramirez J. Pulmonary alveolar proteinosis: treatment by massive bronchopulmonary lavage. Arch Intern Med 1967;119(2):147-156.
156. Zhou B, Zhou HY, Xu PH, Wang HM, Lin XM, Wang XD. Hyperoxygenated solution for improved oxygen supply in patients undergoing lung lavage for pulmonary alveolar proteinosis. Chin Med J (Engl) 2009;122(15):1780-1783.
157. Bingisser R, Kaplan V, Zollinger A, Russi EW. Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest 1998; 113(6):1718-1719.
158. Jansen HM, Zuurmond WW, Roos CM, Schreuder JJ, Bakker DJ. Whole-lung lavage under hyperbaric oxygen conditions for alveolar proteinosis with respiratory failure. Chest 1987;91(6):829-832.
159. Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest 1993;103(5):1409-1412.
160. Kao D, Wasserman K, Costley D, Benfield JR. Advances in the treatment of pulmonary alveolar proteinosis. Am Rev Respir Dis 1975;111(3):361-363.
161. Perez At, Rogers RM. Enhanced alveolar clearance with chest percussion therapy and positional changes during whole-lung lavage for alveolar proteinosis. Chest 2004;125(6):2351-2356.
162. Harris JO, Castle JR, Swenson EW, Block AJ. Lobar lavage: therapeutic benefit in pulmonary alveolar filling disorders. Chest 1974; 65(6):655-659.
163. Ito T, Sato M, Okubo T, Ono I, Akabane J. Infantile pulmonary alveolar proteinosis with interstitial pneumonia: bilateral simultaneous lung lavage utilizing extracorporeal membrane oxygenation and steroid therapy. Tohoku J Exp Med 1999;187(3):279-283.
164. Freedman AP, Pelias A, Johnston RF, Goel IP, Hakki HI, Oslick T, et al. Alveolar proteinosis lung lavage using partial cardiopulmonary bypass. Thorax 1981;36(7):543-545.
165. Brach BB, Harrell JH, Moser KM. Alveolar proteinosis: lobar lavage by fiberoptic bronchoscopic technique. Chest 1976;69(2):224-227.
166. Cheng SL, Chang HT, Lau HP, Lee LN, Yang PC. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest 2002;122(4):1480-1485.
167. Moutafis M, Dalibon N, Colchen A, Fischler M. Improving oxygenation during bronchopulmonary lavage using nitric oxide inhalation and almitrine infusion. Anesth Analg 1999;89(2):302-304.
168. Nagasaka Y, Takahashi M, Ueshima H, Tohda Y, Nakajima S. Bronchoalveolar lavage with trypsin in pulmonary alveolar proteinosis. Thorax 1996;51(7):769-770.
169. Hurrion EM, Pearson GA, Firmin RK. Childhood pulmonary alveolar proteinosis: extracorporeal membrane oxygenation with total cardiopulmonary support during bronchopulmonary lavage. Chest 1994;106(2):638-640.
170. Altose MD, Hicks RE, Edwards MW Jr. Extracorporeal membrane oxygenation during bronchopulmonary lavage. Arch Surg 1976; 111(10):1149-1153.
171. Heymach GJ 3rd, Shaw RC, McDonald JA, Vest JV. Fiberoptic bronchopulmonary lavage for alveolar proteinosis in a patient with only one lung. Chest 1982;81(4):508-510.
172. Nadeau MJ, Cote D, Bussieres JS. The combination of inhaled nitric oxide and pulmonary artery balloon inflation improves oxygenation during whole-lung lavage. Anesth Analg 2004;99(3):676-679.
173. Kavuru MS, Popovich M. Therapeutic whole lung lavage: a stopgap therapy for alveolar proteinosis. Chest 2002;122(4):1123-1124.
174. Bracci L. Role of physical therapy in management of pulmonary alveolar proteinosis: a case report. Phys Ther 1988;68(5):686-689.
175. Hoffman RM, Dauber JH, Rogers RM. Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis. Am Rev Respir Dis 1989;139(4):1030-1032.
176. Bury T, Corhay JL, Saint-Remy P, Radermecker M. [Alveolar proteinosis: restoration of the function of the alveolar macrophages after therapeutic lavage]. Rev Mal Respir 1989;6(4):373-375. Article in French.
177. Du Bois RM, McAllister WA, Branthwaite MA. Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax 1983; 38(5):360-363.
178. Gale ME, Karlinsky JB, Robins AG. Bronchopulmonary lavage in pulmonary alveolar proteinosis: chest radiograph observations. AJR Am J Roentgenol 1986;146(5):981-985.
179. Ben-Abraham R, Greenfeld A, Rozenman J, Ben-Dov I. Pulmonary alveolar proteinosis: step-by-step perioperative care of whole lung lavage procedure. Heart Lung 2002;31(1):43-49.
180. Rogers RM, Szidon JP, Shelburne J, Neigh JL, Shuman JF, Tantum KR. Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med 1972;286(23):1230-1233.
181. Aguinaga MA, Santos P, Renes E, Alvaro PF, Lorente JA, Maudes A, et al. Hemodynamic changes during whole bronchoalveolar lavage in two cases of pulmonary alveolar proteinosis. Intensive Care Med 1991;17(7):421-423.
182. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161(4 Pt 1):1143-1148.
183. Barraclough RM, Gillies AJ. Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 2001;56(8):664-665.
184. Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163(2):524-531.
185. de Vega MG, Sanchez-Palencia A, Ramirez A, Cervera S, Aneiros J. GM-CSF therapy in pulmonary alveolar proteinosis. Thorax 2002; 57(9):837.
186. Schoch OD, Schanz U, Koller M, Nakata K, Seymour JF, Russi EW, et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax 2002;57(3):277-280.
187. Khanjari F, Watier H, Domenech J, Asquier E, Diot P, Nakata K. GM-CSF and proteinosis. Thorax 2003;58(7):645.
188. Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006;130(1):227-237.
189. Price A, Manson D, Cutz E, Dell S. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Pediatr Pulmonol 2006;41(4):367-370.
190. Wylam ME, Ten R, Prakash UB, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 2006;27(3): 585-593.
191. Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, et al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol 2008;43(8):828-830.
192. Lieschke GJ, Cebon J, Morstyn G. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989;74(8):2634-2643.
193. Alberti A, Luisetti M, Braschi A, Rodi G, Iotti G, Sella D, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis: early changes after therapeutic lavage. Am J Respir Crit Care Med 1996;154(3 Pt 1):817-820.
194. Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J 2009;33(5):1220-1222.
195. Borie R, Debray MP, Laine C, Aubier M, Crestani B. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J 2009;33(6):1503-1506.
196. Amital A, Dux S, Shitrit D, Shpilberg O, Kramer MR. Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis. Thorax 2010;65(11):1025-1026.
197. Arora PL, Rogers RM, Mayock RL. Alveolar proteinosis: experience with trypsin therapy. Am J Med 1968;44(6):889-899.
198. Brodsky I, Mayock RL. Pulmonary alveolar proteinosis: remission after therapy with trypsin and chymotrypsin. N Engl J Med 1961; 265:935-938.
199. Cho K, Nakata K, Ariga T, Okajima S, Matsuda T, Ueda K, et al. Successful treatment of congenital pulmonary alveolar proteinosis with intravenous immunoglobulin G administration. Respirology 2006;11(Suppl):S74-S77.
200. Diaz JP, Manresa Presas F, Benasco C, Guardiola J, Munoz L, Clariana A. Response to surfactant activator (ambroxol) in alveolar proteinosis. Lancet 1984;1(8384):1023.
201. Felts JH. Aerosol enzymatic debridement for pulmonary alveolar proteinosis. N C Med J 1965;26:336-338.
202. Gumpert BC, Nowacki MR, Amundson DE. Pulmonary alveolar lipoproteinosis: remission after antibiotic treatment. West J Med 1994;161(1):66-68.
203. Hashizume T. Pulmonary alveolar proteinosis successfully treated with ambroxol. Intern Med 2002;41(12):1175-1178.